Biotechnology - Boston, Massachusetts, United States
AbVitro is an immuno-oncology discovery company, with a cutting edge technology platform that allows for the discovery of cancer specific tumor infiltrating lymphocytes from natural immune response for the development of novel immunotherapies. Based on technology developed by the visionary George Church at Harvard Medical School, our technology allows for the identification of complete, natively paired B cell antibodies and T cell receptors across millions of single cells simultaneously at unprecedented resolution. Our platform enables the discovery of novel cancer specific targets and the development of monoclonal antibodies, antibody drug conjugates, TCRs and CAR T immunotherapies.
CSC Corporate Domains